Page last updated: 2024-11-06

floxuridine and Antibody Deficiency Syndrome

floxuridine has been researched along with Antibody Deficiency Syndrome in 1 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toivanen, P1
Toivanen, A1
Ruotsalainen, P1
Antti-Poika, I1

Other Studies

1 other study available for floxuridine and Antibody Deficiency Syndrome

ArticleYear
Transplantation of lymphoid cells into immunodeficient chickens. Dissociation in the reconstitution of B and T cell functions.
    Clinical immunology and immunopathology, 1975, Volume: 3, Issue:3

    Topics: Age Factors; Animals; Animals, Newborn; Antibody Formation; Antigens; Antigens, Bacterial; B-Lymphoc

1975